Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing of combination products in both the Pharma and med device industries. This two-day summit features expert insight into CP product development, and the complex quality, safety, and regulatory compliance issues facing the CP market.

The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. This two-day conference brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.